Evidence map›Paper›PMID 34956117›Full record

ArticleFrontiers in microbiology2021

Whole-Genome Sequencing-Based Antimicrobial Resistance Characterization and Phylogenomic Investigation of 19 Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Positive

Carine Laurence Yehouenou, Bert Bogaerts, Sigrid C J De Keersmaecker, Nancy H C Roosens, Kathleen Marchal, Edmond Tchiakpe, Dissou Affolabi, Anne Simon, Francis Moise Dossou, Kevin Vanneste and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Genomic Insights of Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Human Riboviruses: A Comprehensive Study.Journal of molecular evolution · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Molecular Epidemiology ofMicroorganisms · 2022
    Article
  12. Review
  13. Antimicrobial-ResistantFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Carine Laurence YehouenouClinical Pharmacy Research Group (CLIP), Louvain Drug Research Institute (LDRI), Université Catholique de Louvain UCLouvain, Brussels, Belgium.
Bert BogaertsTransversal activities in Applied Genomics, Sciensano, Brussels, Belgium.
Sigrid C J De KeersmaeckerTransversal activities in Applied Genomics, Sciensano, Brussels, Belgium.
Nancy H C RoosensTransversal activities in Applied Genomics, Sciensano, Brussels, Belgium.
Kathleen MarchalDepartment of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium.
Edmond TchiakpeLaboratory of Cell Biology and Physiology, Department of Biochemistry and Cellular Biology Faculty of Sciences and Technology and Institute of Applied Biomedical Sciences (ISBA), University of Abomey-Calavi, Cotonou, Benin.
Dissou AffolabiLaboratoire de Référence des Mycobactéries (LRM), Cotonou, Benin.
Anne SimonCentres hospitaliers Jolimont, prevention et contrôle des infections, Haine-Saint-Paul, Belgium.
Francis Moise DossouDepartment of Surgery and Surgical Specialties, Faculty of Health Sciences, Campus universitaire champ de foire, Cotonou, Benin.
Kevin VannesteTransversal activities in Applied Genomics, Sciensano, Brussels, Belgium.
Olivia DalleurClinical Pharmacy Research Group (CLIP), Louvain Drug Research Institute (LDRI), Université Catholique de Louvain UCLouvain, Brussels, Belgium.
Sciensano (Belgium) · BEUniversité d'Abomey-Calavi · BJAidjan-Lagos Corridor Organization · BJGhent University · BEHôpital de Jolimont · BESurgical Specialties (United States) · USUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing worldwide prevalence of extended-spectrum beta-lactamase (ESBL) producing

Indexed as

antimicrobial resistanceBeninEscherichia coliextended-spectrum beta-lactamaseswhole-genome sequencing

Identifiers

PMID34956117
PMCPMC8695880
OpenAlexW4200200783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.